Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

QRA 244

Next Previous
X
Search
Drug Profile

QRA 244

Alternative Names: QRA-244; QRL-101

Latest Information Update: 12 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eli Lilly and Company
  • Developer QurAlis Corporation
  • Class Neuroprotectants
  • Mechanism of Action KCNQ2 potassium channel stimulants; KCNQ3 potassium channel stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Amyotrophic lateral sclerosis

Most Recent Events

  • 13 Apr 2024 QurAlis Corporation plans a phase I trial for Amyotrophic lateral sclerosis (PO)
  • 07 Jan 2024 QurAlis Corporation initiates a phase I trial in healthy volunteers in the Netherland (NCT06532396)
  • 27 Dec 2023 QurAlis Corporation completes a phase I trial in Amyotrophic lateral sclerosiss (In volunteers) in Netherlands (PO) (NCT05667779) (EudraCT2022-002484-30)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top